Symbiotec Pharmalab IPO Subscribed 5.34x on Day 3
5paisa Capital Ltd
- 2 min read
Last Updated: 26th August 2026 - 04:30 pm
Symbiotec Pharmalab IPO was subscribed 5.34 times by 5:24 PM on Day 3, August 26, 2026. The public issue received bids for 6,64,93,485 shares against 1,24,60,533 shares available for subscription. The Non-Institutional Investors (NIIs) category recorded the highest subscription at 11.99 times, followed by the Employee (EMP) category at 6.03 times. Retail Investors subscribed 5.18 times, while Qualified Institutional Buyers (QIBs) subscribed 0.62 times.
Invest in Indian Markets and Unlock Future Potential With 5paisa!Subscription Status of Symbiotec Pharmalab IPO
| Date | QIB | NII | Retail | EMP | Total |
|---|---|---|---|---|---|
| Day 1 (August 24) | 0.37 | 1.03 | 0.96 | 1.59 | 0.81 |
| Day 2 (August 25) | 0.57 | 2.67 | 2.08 | 2.90 | 1.78 |
| Day 3 (August 26) | 0.62 | 11.99 | 5.18 | 6.03 | 5.34 |
Here are the subscription details for Symbiotec Pharmalab IPO Day 3, as of 5:24 PM:
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total |
|---|---|---|---|---|
| Anchor | 1 | 53,25,909 | 53,25,909 | 526.200 |
| QIB | 0.62 | 35,50,608 | 21,98,985 | 217.260 |
| NII | 11.99 | 26,62,955 | 3,19,30,815 | 3,154.765 |
| Retail | 5.18 | 62,13,562 | 3,21,62,235 | 3,177.629 |
| EMP | 6.03 | 33,408 | 2,01,450 | 19.903 |
| Total | 5.34 | 1,24,60,533 |
6,64,93,485 |
6,569.556 |
Key Highlights – Day 3
- Overall subscription stood at 5.34 times on Day 3 (August 26, 2026).
- Qualified Institutional Buyers (QIBs) subscribed 0.62 times.
- Non-Institutional Investors (NIIs) subscribed 11.99 times, the highest.
- Retail Investors subscribed 5.18 times.
- Employee (EMP) category subscribed 6.03 times.
Key Highlights – Day 2
- Overall subscription stood at 1.78 times on Day 2 (August 25, 2026).
- Qualified Institutional Buyers (QIBs) subscribed 0.57 times.
- Non-Institutional Investors (NIIs) subscribed 2.67 times.
- Retail Investors subscribed 2.08 times.
- Employee (EMP) category subscribed 2.90 times, the highest.
Key Highlights – Day 1
- Overall subscription stood at 0.81 times on Day 1 (August 24, 2026).
- Qualified Institutional Buyers (QIBs) subscribed 0.37 times.
- Non-Institutional Investors (NIIs) subscribed 1.03 times.
- Retail Investors subscribed 0.96 times.
- Employee (EMP) category subscribed 1.59 times, the highest.
About Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited is a research-driven pharmaceutical and biotechnology company focused on active pharmaceutical ingredients (APIs) and complex pharmaceutical products. The company has capabilities across organic chemistry, biotechnology and complex injectables, with a significant presence in corticosteroid and steroidal-hormone APIs. Its portfolio also includes fermentation-based APIs and contract development and manufacturing services for pharmaceutical and nutraceutical companies. The company operates manufacturing facilities at Rau and Pithampur in Madhya Pradesh and supplies products to global markets.
- FREE IPO Application
- Apply with Ease
- Pre-Apply for IPOs
- UPI Bid Instantly
Trending on 5paisa
5paisa Capital Ltd
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.